Skip to main content
. Author manuscript; available in PMC: 2013 Jun 5.
Published in final edited form as: Eur J Pharmacol. 2012 Jun 5;684(1-3):64–70. doi: 10.1016/j.ejphar.2012.03.025

Fig. 3. Selective Tachykinin NK1 receptor antagonists attenuate repeated opioid-mediated augmentation of spinal TNFα immunoreactivity in rats.

Fig. 3

After drug treatment and behavioral test, the animals were euthanized and their spinal cords were isolated. Lumbar spinal cord segments were homogenized and TNFa immunoreactivty was measured using a Rat TNFα ELISA kit.